| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Background and methodology of MONITOR-GCSF, a pharmaco-epidemiological study of the multi-level determinants, predictors, and clinical outcomes of febrile neutropenia prophylaxis with biosimilar granulocyte-colony stimulating factor filgrastim
|
Gascón, Pere
|
|
2011
|
77 |
3 |
p. 184-197
14 p.
|
artikel
|
| 2 |
Editorial Board
|
|
|
2011
|
77 |
3 |
p. CO2-
1 p.
|
artikel
|
| 3 |
Pazopanib: Clinical development of a potent anti-angiogenic drug
|
Schutz, Fabio A.B.
|
|
2011
|
77 |
3 |
p. 163-171
9 p.
|
artikel
|
| 4 |
Quality of life in geriatric oncology—An evaluation of standard questionnaires in elderly men with urological malignancies
|
Terret, Catherine
|
|
2011
|
77 |
3 |
p. 201-209
9 p.
|
artikel
|
| 5 |
Relative dose intensity of chemotherapy and its impact on outcomes in patients with early breast cancer or aggressive lymphoma
|
Wildiers, Hans
|
|
2011
|
77 |
3 |
p. 221-240
20 p.
|
artikel
|
| 6 |
The combined effect of age and socio-economic status on breast cancer survival
|
Quaglia, Alberto
|
|
2011
|
77 |
3 |
p. 210-220
11 p.
|
artikel
|
| 7 |
Thrombopoietic growth factors in the treatment of immune thrombocytopenic purpura
|
Wang, Tingting
|
|
2011
|
77 |
3 |
p. 172-183
12 p.
|
artikel
|
| 8 |
Update on the MONITOR-GCSF study of biosimilar filgrastim to reduce the incidence of chemotherapy-induced febrile neutropenia in cancer patients: Protocol amendments
|
Gascón, Pere
|
|
2011
|
77 |
3 |
p. 198-200
3 p.
|
artikel
|
Tijdschrift beschrijving